Dinah K. McGruder

Dinah McGruder serves as a Program Point of Contact for the Centers for Disease Control and Prevention, playing a critical role in aligning procurement activities with the agency’s public health mission. She facilitates the acquisition of scientific, diagnostic, and logistical resources essential to disease surveillance, laboratory capacity building, and emergency response operations. Her responsibilities include coordinating requirements development, evaluating vendor capabilities, and ensuring contract compliance with federal procurement regulations. McGruder primarily supports research-driven and technical acquisitions that enable CDC’s operational readiness and data-driven public health interventions. McGruder maintains strong working relationships with leading pharmaceutical and medical supply contractors, including Merck Sharp & Dohme LLC, GlaxoSmithKline LLC, Pfizer Inc., Sanofi Pasteur Inc., and McKesson Specialty Distribution LLC. These partnerships are instrumental in securing vaccines, therapeutics, diagnostic reagents, and specialized distribution services critical to national immunization and outbreak response programs. Her contracting patterns reflect a preference for established industry leaders with proven track records in biologics manufacturing and cold-chain logistics, ensuring reliability and regulatory compliance across high-stakes public health initiatives. Her procurement portfolio demonstrates a balanced approach to socioeconomic goals, with nearly one-third of awards designated for total small business set-asides under FAR 19.5 and a modest but intentional use of 8(a) competed contracts. While the majority of acquisitions remain open to all competitors, McGruder consistently prioritizes opportunities for small businesses in technical service and supply categories, reinforcing CDC’s commitment to inclusive contracting and innovation from diverse vendors. McGruder’s primary procurement focus centers on NAICS 541512 (Computer Systems Design Services) and 334516 (Analytical Laboratory Instrument Manufacturing), reflecting CDC’s emphasis on data analytics infrastructure and advanced diagnostic equipment. She also procures medical supply distribution services under NAICS 423450 and specialized computer hardware under NAICS 334118, supporting real-time surveillance systems and laboratory automation. Her technical expertise lies at the intersection of public health operations and high-precision scientific instrumentation, ensuring that acquired technologies meet rigorous standards for accuracy, interoperability, and biosafety.